Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/177558| Title: | Early experience and quality of life in SBRT prostate cancer boost of 9 Gy in a phase II trial |
| Author: | Ferrer, Ferran Pont, Àngels Blas, Rodolfo de Boladeras, Anna Garin, O. Ventura, Montse Zardoya, Eva Delgado, J. Condom, E. Merino Cabrera, Esperanza Mases, Joel Castells-Esteve, Manel Guix, Inés Suárez-Novo, José Francisco Gonzalez, Javier Almendros, Sonia Garcia, M. Berenguer, Miguel Ángel Garcia, N. Stefanovic, M. Gutierrez, Cristina Picon, Cristina Ferrer, Montserrat Guedea Edo, Ferran |
| Keywords: | Radioteràpia Càncer de pròstata Radiotherapy Prostate cancer |
| Issue Date: | 1-Apr-2019 |
| Publisher: | Elsevier BV |
| Abstract: | Purpose or ObjectiveExtracranial stereotactic body radiation therapy (SBRT) allows delivering high doses per fraction with high accuracy to the prostatic gland in a low number of fractions.Dose escalation in normofractionaded radiation prostate cancer trials showed an increased toxicity.In order to evaluate the feasibility and toxicity of a regimen of a single dose hypofractionated prostate stereotactic boost a phase II study was undertaken. Self-reported quality of life (QOL) measures were also obtained in order to better define the possible deleterious effect of treatment. |
| Note: | Reproducció del document publicat a: https://doi.org/10.1016/S0167-8140(19)31959-0 |
| It is part of: | Radiotherapy and Oncology, 2019, vol. 133, p. S830-S831 |
| URI: | https://hdl.handle.net/2445/177558 |
| Related resource: | https://doi.org/10.1016/S0167-8140(19)31959-0 |
| ISSN: | 0167-8140 |
| Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| PIIS0167814019319590.pdf | 2.28 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
